Clinical Trial Update: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating repeated dosing of a high-dose influenza vaccine in patients with gammopathy (including multiple myeloma and related plasma cell diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma
• Plasma Cell Disorders
• Waldenström Macroglobulinemia

Drugs mentioned

• High-dose influenza vaccine

Snippet

Sponsor: Yale University | Conditions: Influenza, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-30